117 related articles for article (PubMed ID: 29366963)
1. Functional characterization of cell-free expressed K
Cortes S; Barette C; Beroud R; De Waard M; Schaack B
Protein Expr Purif; 2018 May; 145():94-99. PubMed ID: 29366963
[TBL] [Abstract][Full Text] [Related]
2. Functional reconstitution of cell-free synthesized purified K
Renauld S; Cortes S; Bersch B; Henry X; De Waard M; Schaack B
Biochim Biophys Acta Biomembr; 2017 Dec; 1859(12):2373-2380. PubMed ID: 28888365
[TBL] [Abstract][Full Text] [Related]
3. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.
Chang SC; Huq R; Chhabra S; Beeton C; Pennington MW; Smith BJ; Norton RS
FEBS J; 2015 Jun; 282(12):2247-59. PubMed ID: 25864722
[TBL] [Abstract][Full Text] [Related]
4. A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes.
Abbas N; Belghazi M; Abdel-Mottaleb Y; Tytgat J; Bougis PE; Martin-Eauclaire MF
Biochem Biophys Res Commun; 2008 Nov; 376(3):525-30. PubMed ID: 18804453
[TBL] [Abstract][Full Text] [Related]
5. Identification of a new specific Kv1.3 channel blocker, Ctri9577, from the scorpion Chaerilus tricostatus.
Xie S; Feng J; Yu C; Li Z; Wu Y; Cao Z; Li W; He X; Xiang M; Han S
Peptides; 2012 Jul; 36(1):94-9. PubMed ID: 22580271
[TBL] [Abstract][Full Text] [Related]
6. The Kv1.3 K
Varga Z; Tajti G; Panyi G
Biol Futur; 2021 Mar; 72(1):75-83. PubMed ID: 34554500
[TBL] [Abstract][Full Text] [Related]
7. The voltage-gated potassium channel K
Tajti G; Wai DCC; Panyi G; Norton RS
Biochem Pharmacol; 2020 Nov; 181():114146. PubMed ID: 32653588
[TBL] [Abstract][Full Text] [Related]
8. A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3.
Pennington MW; Harunur Rashid M; Tajhya RB; Beeton C; Kuyucak S; Norton RS
FEBS Lett; 2012 Nov; 586(22):3996-4001. PubMed ID: 23063513
[TBL] [Abstract][Full Text] [Related]
9. Potassium secretion by voltage-gated potassium channel Kv1.3 in the rat kidney.
Carrisoza-Gaytán R; Salvador C; Satlin LM; Liu W; Zavilowitz B; Bobadilla NA; Trujillo J; Escobar LI
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F255-64. PubMed ID: 20427469
[TBL] [Abstract][Full Text] [Related]
10. N-Terminal Tagging with GFP Enhances Selectivity of Agitoxin 2 to Kv1.3-Channel Binding Site.
Nekrasova OV; Primak AL; Ignatova AA; Novoseletsky VN; Geras'kina OV; Kudryashova KS; Yakimov SA; Kirpichnikov MP; Arseniev AS; Feofanov AV
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33339256
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the Inhibitory Peptides ShK and HmK with the Voltage-Gated Potassium Channel K
Sanches K; Prypoten V; Chandy KG; Chalmers DK; Norton RS
J Chem Inf Model; 2023 May; 63(10):3043-3053. PubMed ID: 37143234
[TBL] [Abstract][Full Text] [Related]
12. Affinity and selectivity of ShK toxin for the Kv1 potassium channels from free energy simulations.
Rashid MH; Kuyucak S
J Phys Chem B; 2012 Apr; 116(16):4812-22. PubMed ID: 22480371
[TBL] [Abstract][Full Text] [Related]
13. Conformational exchange in the potassium channel blocker ShK.
Iwakawa N; Baxter NJ; Wai DCC; Fowler NJ; Morales RAV; Sugase K; Norton RS; Williamson MP
Sci Rep; 2019 Dec; 9(1):19307. PubMed ID: 31848433
[TBL] [Abstract][Full Text] [Related]
14. Pandinus imperator scorpion venom blocks voltage-gated K+ channels in human lymphocytes.
Péter M; Varga Z; Panyi G; Bene L; Damjanovich S; Pieri C; Possani LD; Gáspár R
Biochem Biophys Res Commun; 1998 Jan; 242(3):621-5. PubMed ID: 9464266
[TBL] [Abstract][Full Text] [Related]
15. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
[TBL] [Abstract][Full Text] [Related]
16. Targeting the ion channel Kv1.3 with scorpion venom peptides engineered for potency, selectivity, and half-life.
Edwards W; Fung-Leung WP; Huang C; Chi E; Wu N; Liu Y; Maher MP; Bonesteel R; Connor J; Fellows R; Garcia E; Lee J; Lu L; Ngo K; Scott B; Zhou H; Swanson RV; Wickenden AD
J Biol Chem; 2014 Aug; 289(33):22704-22714. PubMed ID: 24939846
[TBL] [Abstract][Full Text] [Related]
17. ImKTx1, a new Kv1.3 channel blocker with a unique primary structure.
Chen Z; Hu Y; Han S; Yin S; He Y; Wu Y; Cao Z; Li W
J Biochem Mol Toxicol; 2011; 25(4):244-51. PubMed ID: 21308893
[TBL] [Abstract][Full Text] [Related]
18. A selective blocker of Kv1.2 and Kv1.3 potassium channels from the venom of the scorpion Centruroides suffusus suffusus.
Corzo G; Papp F; Varga Z; Barraza O; Espino-Solis PG; Rodríguez de la Vega RC; Gaspar R; Panyi G; Possani LD
Biochem Pharmacol; 2008 Oct; 76(9):1142-54. PubMed ID: 18786511
[TBL] [Abstract][Full Text] [Related]
19. Blockade of Kv1.3 channels ameliorates radiation-induced brain injury.
Peng Y; Lu K; Li Z; Zhao Y; Wang Y; Hu B; Xu P; Shi X; Zhou B; Pennington M; Chandy KG; Tang Y
Neuro Oncol; 2014 Apr; 16(4):528-39. PubMed ID: 24305723
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics of Kv1.3 ion channel and structural basis of its inhibition by scorpion toxin-OSK1 derivatives.
Bhuyan R; Seal A
Biophys Chem; 2015; 203-204():1-11. PubMed ID: 26001067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
